Tekla World Healthcare Fund sets up up to $150 million at-the-market share sale
The fund entered a distribution agreement dated December 14, 2022, with Foreside Fund Services, allowing it to sell common shares worth up to $150 million at market prices over time. Foreside has also engaged UBS Securities as a sub-placement agent for these sales. The filing does not report any shares sold yet, but future sales could add shares outstanding and raise capital for the fund.
- Up to $150 million of common shares may be offered through Foreside Fund Services as agent, from time to time.
- The fund pays Foreside a 1.00% commission on gross sale proceeds; Foreside pays UBS up to 0.80% of those proceeds.
- Agreements are dated December 14, 2022, under a prospectus supplement and a shelf registration on Form N-2 (File No. 333-267555).
- The fund may not sell shares below current net asset value, excluding distributing commissions or discounts.